Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label
The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn of NAION, a rare cause of sudden vision loss. Here…
The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn of NAION, a rare cause of sudden vision loss. Here…
A CDSCO expert panel recommended a Phase I trial of Indian Immunologicals' live attenuated Zika vaccine, developed with Griffith University and funded by ICMR.
PMV Pharmaceuticals' rezatapopt produced a 48% response rate in platinum-resistant ovarian cancer with TP53 Y220C in the pivotal PYNNACLE trial, with an FDA filing planned…
Mayo Clinic data from ObesityWeek 2026 show GLP-1 users with weakened hearts saw greater one-year gains in heart structure and function than matched non-users, with…
Up to 15 people have died and more than 300 have sought care in Imphal after drinking spurious liquor in Manipur's Chandel district. What we…
The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn…
Pope Leo XIV lung surgery set after doctors found an early-stage nodule. What the Vatican said, what is unknown and what a lung nodule means.
Kenya Ebola outbreak October 2026 update: no new cases after 293 tests, 108 contacts in quarantine, as the Congo outbreak continues.
Philips sleep apnea device recall: a Dutch court rejected shareholders’ bid for an inquiry. What it means for 15 million devices and patients.
The Russia plague lab WHO report finds no evidence of spread after a lab worker’s death in Irkutsk; cause remains undetermined. Key findings.
Think you were exposed to measles? Learn the signs of exposure, symptom timeline, immunity checks and steps to take, from CDC and WHO guidance.
Pennsylvania’s outbreak is the largest measles outbreak in decades for a US state, with over 1,000 cases. How it compares, deaths and vaccine uptake.
US measles cases passed 4,000 in 2026, with infections in 45 states and DC, CDC data show. The numbers, the hotspots and what the data cannot say.
The 340B Drug Pricing Program lawsuit by the AHA targets a federal rebate model that hospitals say would add over $1 billion a year in costs.
Hovilpri FDA approval gives immunocompromised adults an oral option for HSV lesions that resist standard antivirals. Trial data, dosing, safety, launch.
The once-monthly olanzapine injection Weltruza gets FDA approval for adults with schizophrenia. Doses, SOLARIS data, safety and launch timing.